According to CTI BioPharma
's latest financial reports the company has S$78.9 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | S$0.10 B | 21.12% |
2021-12-31 | S$88.47 M | 27.51% |
2020-12-31 | S$69.38 M | 52.88% |
2019-12-31 | S$45.38 M | -50.44% |
2018-12-31 | S$91.58 M | 58.44% |
2017-12-31 | S$57.8 M | -9.23% |
2016-12-31 | S$63.68 M | -64.88% |
2015-12-31 | S$0.18 B | 93.45% |
2014-12-31 | S$93.72 M | 3.26% |
2013-12-31 | S$90.76 M | 47.16% |
2012-12-31 | S$61.67 M | 1.22% |
2011-12-31 | S$60.93 M | 108.86% |
2010-12-31 | S$29.17 M | -45.04% |
2009-12-31 | S$53.08 M | 247.84% |
2008-12-31 | S$15.26 M | -42.19% |
2007-12-31 | S$26.39 M | -68.02% |
2006-12-31 | S$82.55 M | -28.02% |
2005-12-31 | S$0.11 B | -39.33% |
2004-12-31 | S$0.18 B | 21.49% |
2003-12-31 | S$0.15 B | -36.06% |
2002-12-31 | S$0.24 B | -48.64% |
2001-12-31 | S$0.47 B | 76.48% |
2000-12-31 | S$0.26 B | 574.67% |
1999-12-31 | S$39.79 M | 447.79% |
1998-12-31 | S$7.26 M | -51.59% |
1997-12-31 | S$15 M | 94.94% |
1996-12-31 | S$7.69 M |